BUN: what protein, water and kidneys have in common

When the body breaks down protein, the nitrogen ends up as ammonia, which the liver converts into urea. The kidneys filter urea out, and some of it is reabsorbed depending on how much water the body is holding on to. Blood urea nitrogen (BUN) measures the nitrogen in that urea. It is reported in mg/dL in the US; in the UK and Europe "urea" is reported in mmol/L, and to convert BUN in mg/dL to urea in mmol/L multiply by 0.357.

The ranges

There is no guideline "optimal" BUN. It has no target of its own; it is a supporting test read with creatinine and eGFR, which are what KDIGO uses to stage kidney function.

What raises and lowers it

MedlinePlus lists the main causes:

• Raises: dehydration, a high-protein diet, bleeding in the gut (digested blood is protein), heart failure, a recent heart attack, shock, kidney disease, and urinary tract obstruction. Steroids and other drugs that speed protein breakdown also raise it.
• Lowers: liver failure (the liver cannot make urea), a low-protein diet, malnutrition, and overhydration. Pregnancy lowers it too.

The two most common reasons for a slightly raised BUN in a healthy person are not drinking enough before the test and eating a lot of protein. Both are common on a GLP-1, where people often eat less, drink less and deliberately push protein.

What it predicts

In hospital and heart failure settings, BUN is a well-established marker of risk, partly because it reflects how hard the kidneys are holding on to water. In the general population the data are thinner. A cohort of 1,337,452 US veterans without diabetes (Kidney International, 2018) found that a BUN over 25 mg/dL was associated with a higher risk of developing diabetes over a median 4.9 years, hazard ratio 1.23 after accounting for eGFR, and that every 10 mg/dL higher BUN carried a hazard ratio of 1.15. That is observational, in a mostly older male population, and does not establish that urea causes diabetes.

On GLP-1 drugs and weight loss

The pivotal trials do not report BUN as an outcome. The practical link is dehydration. The semaglutide and tirzepatide labels warn of acute kidney injury after vomiting, diarrhoea or poor fluid intake, and in that situation BUN typically rises before or alongside creatinine. A high BUN with a high ratio, drawn during a rough week after a dose step, usually says "drink more and repeat". A rising creatinine as well is a reason to call the prescriber; the hydration and electrolytes guide covers fluid needs.

How to test

• Normal hydration: drink as usual the day before and the morning of the draw.
• Typical protein intake: avoid an unusually large protein meal in the 12 hours before if you want a baseline.
• Note the context: recent vomiting or diarrhoea, steroids, or a heavy training block.
• Always read it with creatinine from the same draw, and calculate the ratio.

A worked example shows why. A BUN of 26 mg/dL with a creatinine of 0.9 gives a ratio near 29: high, and in a well person usually water or protein. The same BUN of 26 with a creatinine of 1.8 gives a ratio near 14, which points at the kidneys and needs a clinician. The BUN is identical; the meaning is not.

Tracking it in Peptide AI

In Peptide AI, BUN sits in the metabolic panel. The app reads it from a lab PDF or manual entry, scores the panel from 0 to 100 alongside an overall grade, flags values that warrant prompt physician consultation, and plots each result against your dose timeline. Protein logged in nutrition tracking appears next to the result, which explains many high readings. Log the draw date, whether you fasted, and anything unusual in the days before, such as illness, a hard session or a dose step, so the next result is compared like with like. Bloodwork tracking shows the series next to the dose log, weight and side effects, and the panels page lists every marker the app groups. More markers are in the bloodwork guides.